Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | ACTA2 |
| Upstream (Parents) |
|---|
| (<<) ACTN1 → ACTA2 |
| (<<) ADAM12 → ACTA2 |
| (<<) ANTXR1 → ACTA2 |
| (<<) BMPR2 → ACTA2 |
| (<<) CDH11 → ACTA2 |
| (<<) DAB2 → ACTA2 |
| (<<) EFEMP2 → ACTA2 |
| (<<) INHBA → ACTA2 |
| (<<) MYL9 → ACTA2 |
| (<<) MYLK → ACTA2 |
| (<<) PCDH7 → ACTA2 |
| (<<) PTRF → ACTA2 |
| (<<) RECK → ACTA2 |
| (<<) SCG5 → ACTA2 |
| (<<) THBS1 → ACTA2 |
| (<<) TIMP2 → ACTA2 |
| (<<) TPM2 → ACTA2 |
| Downstream (Children) |
|---|
| ACTA2 → CHAF1A (>>) |
| ACTA2 → EDN1 (>>) |
| ACTA2 → EDNRA (>>) |
| ACTA2 → EMP1 (>>) |
| ACTA2 → ERP27 (>>) |
| ACTA2 → FAM100B (>>) |
| ACTA2 → FBXO32 (>>) |
| ACTA2 → GSTM3 (>>) |
| ACTA2 → GULP1 (>>) |
| ACTA2 → ISG20 (>>) |
| ACTA2 → LAMB2 (>>) |
| ACTA2 → LIG1 (>>) |
| ACTA2 → LOC399959 (>>) |
| ACTA2 → NEDD4 (>>) |
| ACTA2 → NNMT (>>) |
| ACTA2 → PRDX6 (>>) |
| ACTA2 → RND3 (>>) |
| ACTA2 → SH2D2A (>>) |
| ACTA2 → TPM3 (>>) |
| ACTA2 → TRAF2 (>>) |
| ACTA2 → VIM (>>) |
